Attapulgite, Pectin & Magnesium Trisilicate

25 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2000.0%

Death Rate

Active Ingredients

Attapulgite, Pectin & Magnesium Trisilicate

Administration Routes

OralUnknownTopical

Species Affected

Dog 22

Cat 3

Most Affected Breeds

Retriever - Labrador 4

Domestic Shorthair 3

Terrier - Yorkshire 2

Terrier - Irish Soft-coated Wheaten 2

Shepherd Dog - German 2

Shepherd Dog - Australian 1

Crossbred Canine/dog 1

Doberman Pinscher 1

Schnauzer (unspecified) 1

Boxer (German Boxer) 1

Most Reported Reactions

Diarrhoea 13

Vomiting 13

Other abnormal test result NOS 9

Anorexia 7

Lethargy (see also Central nervous system depression in 'Neurological') 5

Elevated creatinine 5

Elevated blood urea nitrogen (BUN) 5

Abnormal radiograph finding 4

Weight loss 4

Death by euthanasia 4

Elevated alanine aminotransferase (ALT) 3

Elevated serum alkaline phosphatase (SAP) 3

Outcome Breakdown

Ongoing

13 (52.0%)

Recovered/Normal

6 (24.0%)

Euthanized

4 (16.0%)

Outcome Unknown

1 (4.0%)

Died

1 (4.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.